IGM Biosciences price target lowered to $1 from $2 at Truist

finance.yahoo.com/news/igm-biosciences-price-target-lowered-132025101.html

In This Article:
Truist lowered the firm’s price target on IGM Biosciences (IGMS) to $1 from $2 and keeps a Hold rating on the shares. The firm has updated tis model to reflect Q1 financial results and the company’s forward outlook, adding that it is waiting for any potential announcement…

This story appeared on finance.yahoo.com, 2025-06-12 13:20:25.
The Entire Business World on a Single Page. Free to Use →